Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"surrogate endpoint"”.
-
Magnetic resonance imaging lesion count as a surrogate endpoint in relapsing-remitting multiple sclerosis clinical trials
… imaging (MRI) is often used as a potential surrogate endpoint in phase 2 clinical trials for relapsing-remitting multiple sclerosis (RRMS) patients. However, this surrogacy relationship has not been completely validated. In this report, we study whether at the trial level, the MRI lesion …
-
Search for valid surrogate endpoints: review of current evidence and development of practical strategies for surrogate evaluation
… pursuit of more quickly available treatments, surrogate endpoint evaluation has become a vital part of drug development. Despite the increasing uptake of surrogate endpoints and the large number of statistical methods proposed to evaluate a surrogate, there is still no consensus on how to …
-
The association between binary surrogate endpoints and time-to-event outcomes in two-arm clinical trials
… in breast cancer clinical trials as a surrogate endpoint for long-term survival outcome. We evaluated if and when a binary intermediate endpoint, like pCR, could be viewed as a surrogate endpoint for Event-Free Survival (EFS) and/or Overall Survival (OS) in neoadjuvant cancer treatment …
-
Surrogate endpoints of survival in metastatic carcinoma
… quantified (1). Using an early proxy, or a surrogate endpoint, in place of the direct endpoint of overall survival (OS) could theoretically shorten the duration of RCTs and minimise the exposure of patients to ineffective or toxic treatments (2, 3). This thesis examined the relationship …
-
Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials.
Surrogate endpoints are desirable in clinical trials when primary endpoints are costly to obtain, difficult to measure, or require lengthy follow-up to observe. Despite legitimate concerns, evaluation of potentially beneficial treatments in some settings remains impossible or implausible without …
-
Strategies to accelerate evidence generation and application in colorectal cancer care
… electronic consenting (e-consenting) and surrogate endpoint use in RCTs as acceleratory strategies. First, OncoSim-CRC was used to support timely re-evaluation of national screening guidance due to rising rates of early-onset CRC by modelling the economic impacts of earlier screening. In a …
-
New methods for clinical trials with complex outcomes using surrogate and prioritized composite endpoints
In clinical trials, surrogate and composite endpoints can be used to increase the efficiency of the trial. The first section of this dissertation focuses on the validation of surrogate endpoints where current methodology encounters challenges in the presence of collinearity between the treatment …
-
Μελέτη των προϊόντων σύνθεσης και αποδόμησης του κολλαγόνου τύπου-Ι στη χρόνια καρδιακή ανεπάρκεια
… clinical examination were performed. The primary endpoint of the study was cardiac mortality during a 12 months follow- up. The secondary endpoint was the rehospitalization for decompensation of CHF during a 12 months follow- up. Finally, we assessed a surrogate endpoint, which was the association …
-
Propuesta de un nuevo biomarcador para los trasplantados renales sobre la base del estudio de tecnologias de salud codependientes
… in the peripheral blood, which constitutes a "surrogate" endpoint for a relevant health outcome for kidney transplant recipients, the stability of kidney graft function, defined as a low frequency of acute allograft dysfunction (AAD) events. To date, only serum creatinine measurement is …
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging & Fluorescence Microscopy of Tumor Microvascular Permeability
… that this biomarker will evolve into a clinical surrogate endpoint and be integrated into protocols for determining patient response to antiangiogenic or antivascular therapies. The goal of this research is to develop a method by which microvascular permeability (Ktrans) and vascular volume (vp) …
-
Impact of Informative Censoring on Statistics Used in the Validation of Surrogate Endpoints in Oncology
… (TTP), have been increasingly used as surrogate endpoints for overall survival (OS) in clinical trials in oncology. An issue occurs when clinical trials which demonstrated statistically significant treatment effect for the surrogate marker, shows no significant effect on the true …
-
Biomarkers predicting outcomes for melanoma patients receiving systemic treatment
… pathologic complete response (pCR) as a surrogate endpoint for favorable long-term clinical outcomes. In melanoma, multiple studies have now reported benefit for patients treated with neoadjuvant therapy. Furthermore, the neoadjuvant platform has provided critical insight regarding …
-
New statistical methods with the restricted mean survival time for randomized controlled trials
… sample size. Second, I present a method for surrogate endpoint evaluation using a counterfactual mediation model when both the surrogate and clinical outcome are right censored. I implement an illness-death model for risk prediction and define the direct and indirect effects and the …
-
Genetic mutations and alterations in cell proliferation and apoptosis in UV-induced skin cancer: Application of biomarkers to human chemoprevention studies
… AK, through cancer chemoprevention. We applied surrogate endpoint biomarkers (SEBs) to skin cancer chemoprevention trials in subjects with multiple AK lesions. The primary SEB in these studies was reduction in the number of premalignant AK lesions, while secondary SEBs included p53 mutation …
-
Assessment of coronary artery plaque progression using 64 slice multi-detector computed tomography (MDCT)
… in plaque volume and then it would be used as a surrogate endpoint in clinical trials testing the efficacy of anti-atherosclerotic therapy. OBJECTIVES: To evaluated the progression of atherosclerotic plaque during follow-up interval and its association with cardiovascular risk profile. MATERIALS …
-
Aorto-Coronary Haemodynamics: Studies in Cardiovascular Magnetic Resonance
… novel insight, not only as a potential clinical surrogate endpoint, but also a manner to evaluate therapeutic efficacy.
-
Improving Breast Health: The Use of Hormonal Combinations to Reduce Mammographic Breast Density and the Utility of Shear Wave Elastography as a Biomarker of the Effects of these Interventions
… breast cancer. So much so, it has been used as a surrogate endpoint in breast cancer intervention trials. Mammographic breast density does have its flaws, especially when being used to monitor therapeutic interventions used to reduce breast cancer risk in clinical practice or clinical trials. To …
-
Analyzing Factors Impacting Time to Full Approval of Innovative Drugs via an Accelerated Approval Pathway in the United States
… 30, 2021) of Accelerated Approvals Based on a Surrogate Endpoint. Results: Out of 269 applications in the accelerated approval program since inception, 67% (N=179) were in the oncology therapeutic area, 10% (N=28) of applications in the program involved a therapy that required an FDA approved …
-
Response Adaptive Randomization using Surrogate and Primary Endpoints
… randomizations usually assume that the primary endpoint can be obtained quickly after the treatment. However, in real clinical trials, the primary outcome is delayed, making it unusable for adaptation. Therefore, we utilize surrogate and primary endpoints simultaneously to adaptively assign …
-
Evaluating Heterogeneity in Treatment Effects and Economic Value of Tumor-Agnostic Drugs
… high heterogeneity and uncertainty in survival endpoints, including median progression-free survival (PFS) and median overall survival (OS), although the treatment effects are more similar when judged by surrogate endpoint at approval. Metrics such as intra-class correlation can be used to …
Page 1 of 2